vs
Encompass Health Corp（EHC）とTri Pointe Homes, Inc.（TPH）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $972.6M、Tri Pointe Homes, Inc.の約1.6倍）。Encompass Health Corpの純利益率が高く（9.5% vs 6.2%、差は3.3%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs -22.4%）。Tri Pointe Homes, Inc.の直近四半期フリーキャッシュフローが多い（$213.2M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 1.8%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
Tri Pointe Homes, Inc.はネバダ州インクラインビレッジに本社を置く住宅建設会社で、住宅購入者向けに融資・保険サービスも提供している。アリゾナ、カリフォルニア、ネバダ、ワシントン、コロラド、テキサス、コロンビア特別区、メリーランド、ノースカロライナ、サウスカロライナ、バージニアで事業を展開し、竣工戸数ベースで米国第18位の住宅建設企業である。
EHC vs TPH — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $972.6M |
| 純利益 | $146.1M | $60.2M |
| 粗利率 | — | — |
| 営業利益率 | 16.7% | 8.1% |
| 純利益率 | 9.5% | 6.2% |
| 売上前年比 | 9.9% | -22.4% |
| 純利益前年比 | 20.8% | -53.4% |
| EPS（希薄化後） | $1.43 | $0.70 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $972.6M | ||
| Q3 25 | $1.5B | $854.7M | ||
| Q2 25 | $1.5B | $902.4M | ||
| Q1 25 | $1.5B | $740.9M | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.3B | $939.4M |
| Q4 25 | $146.1M | $60.2M | ||
| Q3 25 | $126.5M | $56.1M | ||
| Q2 25 | $142.1M | $60.7M | ||
| Q1 25 | $151.5M | $64.0M | ||
| Q4 24 | $120.9M | $129.2M | ||
| Q3 24 | $108.2M | $111.8M | ||
| Q2 24 | $114.1M | $118.0M | ||
| Q1 24 | $112.5M | $99.1M |
| Q4 25 | 16.7% | 8.1% | ||
| Q3 25 | 14.9% | 8.1% | ||
| Q2 25 | 16.2% | 8.5% | ||
| Q1 25 | 16.4% | 10.4% | ||
| Q4 24 | 14.3% | 13.4% | ||
| Q3 24 | 13.6% | 12.6% | ||
| Q2 24 | 14.3% | 12.9% | ||
| Q1 24 | 13.6% | 12.3% |
| Q4 25 | 9.5% | 6.2% | ||
| Q3 25 | 8.6% | 6.6% | ||
| Q2 25 | 9.7% | 6.7% | ||
| Q1 25 | 10.4% | 8.6% | ||
| Q4 24 | 8.6% | 10.3% | ||
| Q3 24 | 8.0% | 9.8% | ||
| Q2 24 | 8.8% | 10.2% | ||
| Q1 24 | 8.5% | 10.5% |
| Q4 25 | $1.43 | $0.70 | ||
| Q3 25 | $1.24 | $0.64 | ||
| Q2 25 | $1.39 | $0.68 | ||
| Q1 25 | $1.48 | $0.70 | ||
| Q4 24 | $1.18 | $1.37 | ||
| Q3 24 | $1.06 | $1.18 | ||
| Q2 24 | $1.12 | $1.25 | ||
| Q1 24 | $1.10 | $1.03 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $982.8M |
| 総負債低いほど良い | $2.4B | — |
| 株主資本純資産 | $2.4B | $3.3B |
| 総資産 | $7.1B | $5.0B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $982.8M | ||
| Q3 25 | $48.7M | $792.0M | ||
| Q2 25 | $99.1M | $622.6M | ||
| Q1 25 | $95.8M | $812.9M | ||
| Q4 24 | $85.4M | $970.0M | ||
| Q3 24 | $147.8M | $676.0M | ||
| Q2 24 | $154.4M | $492.9M | ||
| Q1 24 | $134.4M | $944.0M |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $646.5M | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $2.4B | $3.3B | ||
| Q3 25 | $2.4B | $3.3B | ||
| Q2 25 | $2.3B | $3.3B | ||
| Q1 25 | $2.2B | $3.3B | ||
| Q4 24 | $2.1B | $3.3B | ||
| Q3 24 | $2.0B | $3.2B | ||
| Q2 24 | $1.8B | $3.1B | ||
| Q1 24 | $1.7B | $3.0B |
| Q4 25 | $7.1B | $5.0B | ||
| Q3 25 | $6.9B | $5.0B | ||
| Q2 25 | $6.8B | $4.8B | ||
| Q1 25 | $6.6B | $4.8B | ||
| Q4 24 | $6.5B | $4.9B | ||
| Q3 24 | $6.5B | $4.8B | ||
| Q2 24 | $6.4B | $4.6B | ||
| Q1 24 | $6.2B | $5.0B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | 0.19× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $221.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $213.2M |
| FCFマージンFCF / 売上 | 7.6% | 21.9% |
| 設備投資強度設備投資 / 売上 | 14.8% | 0.8% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 3.67× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $128.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $221.0M | ||
| Q3 25 | $270.8M | $45.9M | ||
| Q2 25 | $270.2M | $-74.3M | ||
| Q1 25 | $288.6M | $-31.2M | ||
| Q4 24 | $278.8M | $360.3M | ||
| Q3 24 | $267.8M | $167.9M | ||
| Q2 24 | $217.4M | $23.1M | ||
| Q1 24 | $238.8M | $144.7M |
| Q4 25 | $116.7M | $213.2M | ||
| Q3 25 | $83.7M | $39.1M | ||
| Q2 25 | $113.3M | $-84.5M | ||
| Q1 25 | $125.5M | $-39.3M | ||
| Q4 24 | $80.1M | $355.9M | ||
| Q3 24 | $120.3M | $161.5M | ||
| Q2 24 | $60.5M | $17.0M | ||
| Q1 24 | $99.4M | $138.3M |
| Q4 25 | 7.6% | 21.9% | ||
| Q3 25 | 5.7% | 4.6% | ||
| Q2 25 | 7.8% | -9.4% | ||
| Q1 25 | 8.6% | -5.3% | ||
| Q4 24 | 5.7% | 28.4% | ||
| Q3 24 | 8.9% | 14.1% | ||
| Q2 24 | 4.6% | 1.5% | ||
| Q1 24 | 7.6% | 14.7% |
| Q4 25 | 14.8% | 0.8% | ||
| Q3 25 | 12.7% | 0.8% | ||
| Q2 25 | 10.8% | 1.1% | ||
| Q1 25 | 11.2% | 1.1% | ||
| Q4 24 | 14.1% | 0.3% | ||
| Q3 24 | 10.9% | 0.6% | ||
| Q2 24 | 12.1% | 0.5% | ||
| Q1 24 | 10.6% | 0.7% |
| Q4 25 | 2.37× | 3.67× | ||
| Q3 25 | 2.14× | 0.82× | ||
| Q2 25 | 1.90× | -1.22× | ||
| Q1 25 | 1.90× | -0.49× | ||
| Q4 24 | 2.31× | 2.79× | ||
| Q3 24 | 2.48× | 1.50× | ||
| Q2 24 | 1.91× | 0.20× | ||
| Q1 24 | 2.12× | 1.46× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
TPH
| West | $547.8M | 56% |
| Central | $245.1M | 25% |
| East | $161.8M | 17% |
| Financial Services Segment | $18.0M | 2% |
| Land | $7.9M | 1% |
